A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa	Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Injuries, Craniocerebral Trauma, Eye Injuries, Facial Injuries, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, corneal disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, eye disorder, hereditary disease, hereditary skin disorder, injury, nervous system disorder, nervous system injury, recessive dystrophic epidermolysis bullosa, skin disorder, vesiculobullous skin disease	Recruiting	Phase 3	2026-03-12		NCT07016750

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Krystal Biotech, Inc.	11

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Mission dermatology Center	Rancho Santa Margarita	United States	6
Skin Research Institute	Coral Gables	United States	3
Texas Dermatology and Laser Specialists	San Antonio	United States	25
UMass Memorial Medical Center	Worcester	United States	11